Zebrafish as a potential model organism for drug test against hepatitis C virus

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Ding, Cun Bao ^a,b   Zhang, Jing Pu ^a   Zhao, Ye ^a   Peng, Zong Gen ^a   Song, Dan Qing ^a   Jiang, Jian Dong ^a,c  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

^b HEBEI POLYTECHNIC UNIVERSITY   (China)

^c INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; OXYMATRINE; RIBAVIRIN; VIRUS RNA; ALKALOID; ANTIVIRUS AGENT; GREEN FLUORESCENT PROTEIN; NS 5 PROTEIN, HEPATITIS C VIRUS; NS-5 PROTEIN, HEPATITIS C VIRUS; QUINOLIZINE DERIVATIVE; VIRUS PROTEIN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG SCREENING; EMBRYO; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; LARVAL STAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REPLICON; REPRODUCIBILITY; VIRUS CELL INTERACTION; VIRUS REPLICATION; ZEBRA FISH; ZYGOTE; ANIMAL; DRUG EFFECT; FISH DISEASE; FLUORESCENCE MICROSCOPY; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; HUMAN; IN SITU HYBRIDIZATION; LARVA; LIVER CELL; METABOLISM; METHODOLOGY; MICROINJECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNTRANSLATED REGION; VIROLOGY; WESTERN BLOTTING;

ANIMALIA; DANIO RERIO; HEPATITIS C VIRUS;

ALKALOIDS; ANIMALS; ANTIVIRAL AGENTS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FISH DISEASES; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HUMANS; IN SITU HYBRIDIZATION; LARVA; MICROINJECTIONS; MICROSCOPY, FLUORESCENCE; QUINOLIZINES; REPLICON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBAVIRIN; UNTRANSLATED REGIONS; VIRAL NONSTRUCTURAL PROTEINS; ZEBRAFISH;

EID: 79961174974     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022921     Document Type: Article

References (38)

1. Piai G, Scalice E, Focareta R, Terracciano F, de Filippo FR, et al. (2006) From trials to a real hospital setting: effectiveness of pegylated interferon-alpha-2b/ribavirin combination therapy for naïve chronic hepatitis C patients. Dig Dis Sci 51: 1619-1626.
2. Qureshi SA, (2007) Hepatitis C virus--biology, host evasion strategies, and promising new therapies on the horizon. Med Res Rev 27: 353-373.
3. Webster DP, Klenerman P, Collier J, Jeffery KJ, (2009) Development of novel treatments for hepatitis C. Lancet Infect Dis 9: 108-117.
4. Thompson AJ, McHutchison JG, (2009) Review article: investigational agents for chronic hepatitis C. Aliment Pharmacol Ther 29: 689-705.
5. Ploss A, Rice CM, (2009) Towards a small animal model for hepatitis C. EMBO Rep 10: 1220-1227.
6. Barth H, Robinet E, Liang TJ, Baumert TF, (2008) Mouse models for the study of HCV infection and virus-host interactions. J Hepatol 49: 134-142.
7. Koike K, Moriya K, Matsuura Y, (2010) Animal models for hepatitis C and related liver disease. Hepatol Res 40: 69-82.
8. Boonstra A, van der Laan LJ, Vanwolleghem T, Janssen HL, (2009) Experimental models for hepatitis C viral infection. Hepatology 50: 1646-1655.
9. Lerat H, Honda M, Beard MR, Loesch K, Sun J, et al. (2002) Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 122: 352-365.
10. Lerat H, Kammoun HL, Hainault I, Mérour E, Higgs MR, et al. (2009) Hepatitis C virus proteins induce lipogenesis and defective triglyceride secretion in transgenic mice. J Biol Chem 284: 33466-33474.
11. Tumurbaatar B, Sun Y, Chan T, Sun J, (2007) Cre-estrogen receptor-mediated hepatitis C virus structural protein expression in mice. J Virol Methods 146: 5-13.
12. Suzuki T, Ishii K, Aizaki H, Wakita T, (2007) Hepatitis C viral life cycle. Advanced Drug Delivery Reviews 59: 1200-1212.
13. Gallego J, Varani G, (2002) The hepatitis C virus internal ribosome-entry site: a new target for antiviral research. Biochem Soc Trans 30: 140-145.
14. Bradrick SS, Walters RW, Gromeier M, (2006) The hepatitis C virus 3′-untranslated region or a poly(A) tract promote efficient translation subsequent to the initiation phase. Nucleic Acids Res 34: 1293-1303.
15. Gates AT, Sarisky RT, Gu B, (2004) Sequence requirements for the development of a chimeric HCV replicon system. Virus Res 100: 213-222.
16. Shin JT, Fishman MC, (2002) From Zebrafish to human: modular medical models. Annu Rev Genomics Hum Genet 3: 311-340.
17. Dooley K, Zon LI, (2000) Zebrafish: a model system for the study of human disease. Curr Opin Genet Dev 10: 252-256.
18. Lam SH, Wu YL, Vega VB, Miller LD, Spitsbergen J, et al. (2006) Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression. Nat Biotechnol 24: 73-75.
19. Thisse C, Thisse B, (2008) High-resolution in situ hybridization to whole-mount zebrafish embryos. Nat Protoc 3: 59-69.
20. Hauptmann G, Gerster T, (1994) Two-color whole-mount in situ hybridization to vertebrate and Drosophila embryos. Trends Genet 10: 266.
21. Helbig KJ, Ruszkiewicz A, Semendric L, Harley HA, McColl SR, et al. (2004) Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation. Hepatology 39: 1220-1229.
22. Chang ML, Yeh CT, Chen JC, Huang CC, Lin SM, et al. (2008) Altered expression patterns of lipid metabolism genes in an animal model of HCV core-related, nonobese, modest hepatic steatosis. BMC Genomics 9: 109.
23. Nishimura-Sakurai Y, Sakamoto N, Mogushi K, Nagaie S, Nakagawa M, et al. (2010) Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells. J Gastroenterol 45: 523-536.
24. Harris D, Zhang Z, Chaubey B, Pandey VN, (2006) Identification of cellular factors associated with the 3′-nontranslated region of the hepatitis C virus genome. Mol Cell Proteomics 5: 1006-1018.
25. Parent R, Qu X, Petit MA, Beretta L, (2009) The heat shock cognate protein 70 is associated with hepatitis C virus particles and modulates virus infectivity. Hepatology 49: 1798-1809.
26. Friedman SL, (2008) Mechanisms of Hepatic Fibrogenesis. Gastroenterology 134: 1655-1669.
27. Blais DR, Brûlotte M, Qian Y, Bélanger S, Yao SQ, et al. (2009) Activity-based proteome profiling of hepatoma cells during hepatitis C virus replication using protease substrate probes. J Proteome Res 9: 912-923.
28. Walker MP, Appleby TC, Zhong W, Lau JY, Hong Z, (2003) Hepatitis C virus therapies: current treatments, targets and future perspectives. Antivir Chem Chemother 14: 1-21.
29. Liu J, Manheimer E, Tsutani K, Gluud C, (2003) Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials. Am J Gastroenterol 98: 538-544.
30. Park IW, Ndjomou J, Fan Y, Henao-Mejia J, He JJ, (2009) Hepatitis C virus is restricted at both entry and replication in mouse hepatocytes. Biochem Biophys Res Commun 387: 489-493.
31. Guevin C, Lamarre A, Labonte P, (2009) Novel HCV replication mouse model using human hepatocellular carcinoma xenografts. Antiviral Res 84: 14-22.
32. Chak E, Saab S, (2010) Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response. Curr Hepat Rep 9: 147-154.
33. Mancuso ME, Rumi MG, Aghemo A, Santagostino E, Puoti M, et al. (2009) Hepatitis C virus/human immunodeficiency virus coinfection in hemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapy. J Thromb Haemost 7: 1997-2005.
34. Ling JY, Zhang GY, Cui ZJ, Zhang CK, (2007) Supercritical fluid extraction of quinolizidine alkaloids from Sophora flavescens Ait. and purification by high-speed counter-current chromatography. J Chromatogr A 1145: 123-127.
35. Lu LG, Zeng MD, Mao YM, Li JQ, Wan MB, et al. (2003) Oxymatrine therapy for chronic hepatitis B: a randomized double-blind and placebo-controlled multi-center trial. World J Gastroenterol 9: 2480-2483.
36. Chen YX, Mao BY, Jiang JH, (2002) [Relationship between serum load of HBV-DNA and therapeutic effect of oxymatrine in patients with chronic hepatitis B]. Zhongguo Zhong Xi Yi Jie He Za Zhi 22: 335-336.
37. Li J, Li C, Zeng M, (1998) [Preliminary study on therapeutic effect of oxymatrine in treating patients with chronic hepatitis C]. Zhongguo Zhong Xi Yi Jie He Za Zhi 18: 227-229.
38. Yao YN, Liu P, Wang SE, Zhu L, Dong HJ, (2004) [Study on Acute Toxicity of Mice and Micronucleus in Peripheral Blood and Sperm Abnormality of Mice Induced by Marine]. Carcinogenesis, Teratogenesis and Mutagenesis 16: 110-113.